Zanotto-Filho, A., Rajamanickam, S., Loranc, E., Masamsetti, P., Gorthi, A., Romero, J. C., . . . Bishop, A. J. R. (2018). Sorafenib improves alkylating therapy by blocking induced inflammation, invasion and angiogenesis in breast cancer cells. Cancer Lett.
Chicago Stili AlıntıZanotto-Filho, Alfeu, et al. "Sorafenib Improves Alkylating Therapy By Blocking Induced Inflammation, Invasion and Angiogenesis in Breast Cancer Cells." Cancer Lett 2018.
MLA AlıntıZanotto-Filho, Alfeu, et al. "Sorafenib Improves Alkylating Therapy By Blocking Induced Inflammation, Invasion and Angiogenesis in Breast Cancer Cells." Cancer Lett 2018.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..